The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Intra-Cellular Therapies, Inc(NASDAQ:ITCI) 
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the central nervous system (CNS) in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It i...
Founded: 2002
Full Time Employees: 330
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Intra-Cellular Therapies Days Payable Outstanding ttm (DPO)
Intra-Cellular Therapies Days Receivable Outstanding ttm (DSO)
Intra-Cellular Therapies Days Inventory Outstanding ttm (DIO)
Intra-Cellular Therapies Op Cashflow Per Share ttm
Intra-Cellular Therapies Free Cashflow Per Share ttm
Intra-Cellular Therapies Cash Per Share ttm
Intra-Cellular Therapies P/S ratio ttm
Intra-Cellular Therapies (GAAP) P/E ratio ttm
Intra-Cellular Therapies P/B ratio ttm
No extra charts and metrics for this ticker.